mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.0005 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |